Clinical trial
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical Trial
NCT06142656 is registered in ClinicalTrials.gov with October 6 University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical Trial
- Lead sponsor
- October 6 University
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- November 25, 2023
- Completion date
- February 1, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
poly cystic ovary syndrome